At this juncture, focusing on this issue, the current data from the literature revealed that major medications responsible for provoking acute liver injury in COVID-19 patients are antimalarial and antimicrobial [57], and perhaps ACE2 and hypoxic damage to the liver are the most conceivable mechanism for the development of these ADRs [58,59,60]. Here, ACE2 is linked to COVID-19.